This 8-hour training on opioid and other substance use disorders satisfies the new Drug Enforcement Administration training requirement for prescribers.
Opioid medications are very powerful pain killers, that carry a significant addiction risk. Our nation faces a crisis of overdose deaths from opioids, including heroin, illicit fentanyl, and prescription opioids. According to the Centers for Disease Control and Prevention, more than 100,000 people died of drug overdoses in the United States during the 12-month period May 2020 to April 2021, reflecting a new record high. These deaths represent a mere fraction of the total number of Americans harmed by opioid misuse and addiction. Many Americans now suffer daily from a chronic medical illness called “opioid addiction” or opioid use disorder (OUD). Healthcare professionals, treatment providers, and policymakers have a responsibility to expand access to evidence-based, effective care for people with OUD.
Prescription opioids have been suggested to be an important gateway drug. In fact, opioids should not be first-line treatment for chronic pain, acute mild to moderate pain and dental pain. Health care providers should first consider nonopioid pain relievers or nonpharmacological options.
To mitigate this explosion of opioid-associated morbidity and mortality, Paul Langlois APN, PhD, CCRN, CCNS, presents this training requirement for all DEA-registered practitioners on the treatment and management of patients with opioid and substance use disorder. Treatment of OUD in specialty populations will be highlighted: pregnant women, adolescents, incarcerated personnel and patients with persistent cancer-related pain. Numerous case studies will be used throughout this presentation to solidify the learning experience. Discover conscientious ways to address patient’s pain, while lowering the risk for addiction!
Planning Committee Disclosure - No relevant relationships
All members of the PESI, Inc. planning committee have provided disclosures of financial relationships with ineligible organizations and any relevant non-financial relationships prior to planning content for this activity. None of the committee members had relevant financial relationships with ineligible companies or other potentially biasing relationships to disclose to learners. For speaker disclosures, please see the faculty biography.
NOTE: Tuition includes one free CE Certificate (participant will be able to print the certificate of completion after passing the online post-test (80% passing score) and completing the evaluation). Instructional methods will include PowerPoint, didactic lecture, and others.
Continuing Education Information: Listed below are the continuing education credit(s) currently available for this non-interactive self-study package. Program content is reviewed periodically per accrediting board rules for currency and appropriateness for credit. Credit approvals are subject to change. Please note, your state licensing board dictates whether self-study is an acceptable form of continuing education, as well as which credit types are acceptable for continuing education hours. Please refer to your state rules and regulations. If your profession is not listed, please contact your licensing board to determine your continuing education requirements and check for reciprocal approval.
For other credit inquiries not specified below, please contact info@pesi.com or 800-844-8260 before purchase.
Materials that are included in this course may include interventions and modalities that are beyond the authorized practice of your profession. As a licensed professional, you are responsible for reviewing the scope of practice, including activities that are defined in law as beyond the boundaries of practice in accordance with and in compliance with your profession's standards.
For Planning Committee disclosures, please see the statement above. For speaker disclosures, please see the faculty biography.
Earn up to 8.0 CE hours. Please see below, for more details, as credit amounts vary by state and profession.
This self-study program offers 491 instructional minutes of pharmacology content which is designed to qualify for 8.0 contact hours toward your pharmacology requirement.
PESI, Inc. is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. Nurses completing these self-study materials will earn 8.0 contact hours. Expires: 01/09/2027.
PESI, Inc. is a provider approved by the California Board of Registered Nursing, Provider #: 17118 for 8.0 self-study contact hours.
** You will need to provide your license number to PESI. PESI must have this number on file in order for your hours to be valid.
PESI, Inc. is an approved provider by the Florida Board of Nursing. Provider #: FBN2858. These materials qualify for 8.0 self-study contact hours.
PESI, Inc. is an approved provider by the Iowa Board of Nursing. Provider #: 346. Nurses successfully completing these self-study materials will earn 8.0 self-study contact hours. Please email cepesi@pesi.com with your license number, include the title, speaker name and date. PESI must have this number on file in order for your hours to be valid.
PESI, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. PESI, Inc. designates this enduring material for a maximum of 8.0 AMA PRA Category 1 Credit(s)™. This activity was originally recorded on 01/09/2024. It was last reviewed on 03/15/2024 and is valid until 03/14/2027.
Physicians should only claim credit commensurate with the extent of their participation in the activity. You are required to successfully complete and submit a post-test prior to receiving a certificate of completion.
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME such as PESI. Physician assistants may receive a maximum of 8.0 hours for completing this self-study program. This activity was originally recorded on 01/09/2024. It was last reviewed on 03/15/2024 and is valid until 03/14/2027.
PESI, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. PESI, Inc. designates this enduring material for a maximum of 8.0 AMA PRA Category 1 Credit(s)™.
This self-study activity qualifies for 8.0 continuing education clock hours as required by many national, state and local licensing boards and professional organizations. Save your activity advertisement and certificate of completion, and contact your own board or organization for specific requirements.
| File type | File name | Number of pages | |
|---|---|---|---|
| Manual - Drug Enforcement Administration Training Requirement for Prescribers: Complete 8 Hours on Opioid & Other Substance Use Disorders (12.3 MB) | 108 Pages | Available after Purchase |
Paul Langlois, APN, PhD, CCRN, CCNS, is a critical care clinical specialist in the surgical, medical, neurologic, burn, CCU, and trauma ICUs of Cook County Hospital, Chicago. Drawing on over 40 years of experience assessing and managing patients with life-threatening diseases, Dr. Langlois provides advanced-level training to nurses, physician assistants, nurse practitioners, respiratory therapists, and physicians.
Dr. Langlois is committed to providing the highest quality of care to patients through advanced education. His presentations are evidence-based, timely, and provide participants with numerous case studies to facilitate critical thinking. As a bedside clinical nurse specialist, he has developed several institution-wide protocols for the multidisciplinary assessment and management of infectious disease and multi-system organ failure patients.
His presentations are enthusiastically delivered and offer highly practical tips that help make the most challenging concepts easy to understand. Linking knowledge to clinical practice is the goal of every educational program.
Speaker Disclosures:
Access never expires for this product.
Visit our FAQ page at www.pesi.com/faq or contact us at www.pesi.com/info
Mechanism of Action of Opioids
Criteria for Prescribing Opioids and Nonopioids
Treatment of Subacute and Chronic Pain
Tapering Opioids
State Prescription Drug Monitoring Program
Toxicology Testing
Opioids and Benzodiazepines
Abuse Deterrent Medications
Opioid Use Disorder (OUD)
Diagnosis of OUD using the Diagnostic and Statistical Manual of Mental Disorders
Medications
OUD in pregnancy
OUD in adolescents
OUD in incarcerated imdividuals
OUD in patients with persistent non-cancer related pain
Mechanism for referral to substance abuse specialist
Opioid Overdose and Cardiac Arrest
Satisfaction Guarantee
Your satisfaction is our goal and our guarantee. Concerns should be addressed to: PO Box 1000, Eau Claire, WI 54702-1000 or call 1-800-844-8260.
ADA Needs
We would be happy to accommodate your ADA needs; please call our Customer Service Department for more information at 1-800-844-8260.
PESI Mobile App
Access CE trainings on your phone or tablet through our free mobile app. Choose video or audio-only versions of online courses from the world’s best instructors, and complete your CE requirements anywhere, anytime, at your own pace.
Please wait ...
